AASLD	American Association for the Study of Liver Diseases
ACE	angiotensin-converting enzyme inhibitors
ALT	alanine aminotransferase
APRI	AST to Platelet Ratio Index
ARBs	angiotensin receptor blockers
AST	aspartate transaminase
BMI	body mass index
CAP	controlled attenuation parameter
FIB-4	Fibrosis-4 score
GLP-1	glucagon-like peptide-1 receptor agonists
HbA1c	glycated hemoglobin
HDL	high-density lipoprotein cholesterol
IL-1RA	interleukin-1 receptor antagonist
IR	insulin resistance
LDL	low-density lipoprotein
MAFLD	metabolic-associated fatty liver disease
MASLD	metabolic dysfunction–associated steatotic liver disease
MRI-PDFF	magnetic resonance imaging–proton density fat fraction
miR-660-5p	circulating microRNA-660-5p
NAC	N-acetylcysteine
NAFLD	non-alcoholic fatty liver disease
NHANES	National Health and Nutrition Examination Survey
NASH	non-alcoholic steatohepatitis
PNFI	Pediatric NAFLD Fibrosis Index
PNFS	Pediatric NAFLD Fibrosis Score
sCD163	soluble CD163
TE-CAP	transient elastography with controlled attenuation parameter
TG/HDL-C	triglyceride-to–high-density lipoprotein cholesterol ratio
TyG	triglyceride–glucose index
TyG-WC	triglyceride–glucose index adjusted for waist circumference
WC	waist circumference